The Evolving Treatment Landscape of AML by Sabine Blum, Ulrike Bacher, Thomas Pabst

Get full text

The Evolving Treatment Landscape of AML by Sabine Blum, Ulrike Bacher, Thomas Pabst

Get full text

Editorial: MDS: new scientific and clinical developments by Sabine Blum, Argiris Symeonidis, Ulrich Germing

Get full text

EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT by Sabine Blum, Luca Malcovati, on behalf of the EHA Guidelines Committee*

Get full text

Postpartum hemorrhage risk is driven by changes in blood composition through pregnancy by Matthew R. Robinson, Marion Patxot, Miloš Stojanov, Sabine Blum, David Baud

Get full text

Understanding Myelodysplasia and Inflammation Through the Lense of VEXAS Syndrome: A Review by Louis Wolff, Leo Caratsch, Lin-Pierre Zhao, Sabine Blum, Denis Comte

Get full text

Isolated skin infiltration by a blastic plasmacytoid dendritic cell neoplasm by Grégoire Stalder, Dina Milowich, Sabine Blum, Jacqueline Schoumans, Bettina Bisig, Olivier Spertini

Get full text

Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes by Vasiliki Papadopoulou, Jacqueline Schoumans, Valentin Basset, Françoise Solly, Jérôme Pasquier, Sabine Blum, Olivier Spertini

Get full text

Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine by Mathilde Gavillet, Jasmine Noetzli, Sabine Blum, Michel A. Duchosal, Olivier Spertini, Jean-Francois Lambert

Get full text

Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma by Sophie Voruz, Anne Cairoli, Olaia Naveiras, Laurence de Leval, Edoardo Missiaglia, Krisztian Homicsko, Olivier Michielin, Sabine Blum

Get full text

Comment on “MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma” by Sophie Voruz, Filipe Martins, Anne Cairoli, Olaia Naveiras, Krisztian Homicsko, Edoardo Missiaglia, Laurence de Leval, Bettina Bisig, Olivier Michielin, Sabine Blum

Get full text

P361: HIGH REMISSION AND SURVIVAL RATE IN ADULTS WITH MINIMAL RESIDUAL DISEASE-POSITIVE OR RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA TREATED WITH BLINATUMOMAB IN ROU... by Sabina Chiaretti, Sabine Blum, Thibaut Leguay, Marie Balsat, Cyril Salek, Nicola Fracchiolla, Alexandros Spyridonidis, Anita Rijneveld, Cristina Papayannidis, Sofia Ganzha, Reetabrata Bhattacharyya, Gerhard Zugmaier, Isabella Pezzani Grueter, Andreas Ochs, Alessandro Rambaldi

Get full text

Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced... by Jeanne Mendell, Daniel J. Freeman, Wenqin Feng, Thore Hettmann, Matthias Schneider, Sabine Blum, Jens Ruhe, Johannes Bange, Kenji Nakamaru, Shuquan Chen, Zenta Tsuchihashi, Joachim von Pawel, Catherine Copigneaux, Robert A. Beckman

Get full text

Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leuk... by Sabine Blum, Yves Chalandon, Myriam Labopin, Jürgen Finke, Tobias Gedde-Dahl, Tarek Ben Othman, Jan J. Cornelissen, Pavel Jindra, Hélène Labussière-Wallet, Matthew Collin, Stig Lenhoff, Guido Kobbe, Norma C. Gutiérrez, Arnon Nagler, Mohamad Mohty

Get full text

P315: TP53 ALTERATIONS AND MRD REFINE PROGNOSIS OF ADULT KMT2A-REARRANGED B-ALL by Rathana Kim, Hugo Bergugnat, Florence Pasquier, Emmanuel Raffoux, Lise Larcher, Marie Passet, Cedric Pastoret, Grardel Nathalie, Vahid Asnafi, Eric Delabesse, Aurélie Caye-Eude, Claus Meyer, Rolf Masrschalek, Anne Thiebaut-Bertrand, Marie Balsat, Martine Escoffre, Sabine Blum, Michael Baumann, Anne Banos, Nicole Straetmans, Maria Pilar Gallego Hernanz, Yves Chalandon, Carlos Graux, Thibaut Leguay, Mathilde Hunault, Françoise Huguet, Véronique Lhéritier, Jean Soulier, Nicolas Boissel, Emmanuelle Clappier

Get full text

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine by Jacobien R. Hilberink, Isabelle A. van Zeventer, Dana A. Chitu, Thomas Pabst, Saskia K. Klein, Georg Stussi, Laimonas Griskevicius, Peter J. M. Valk, Jacqueline Cloos, Arjan A. van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus G. Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W. M. van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J. Ossenkoppele, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK), Gerwin Huls

Get full text